Similar articles

• Hormonal treatment of malignancy of the breast and prostate.

  TEAHAN RW. TEAHAN RW. J Albert Einstein Med Cent (Phila). 1955 May;3(3):96-8. J Albert Einstein Med Cent (Phila). 1955. PMID: 14381166 No abstract available.
• [Prostatic hormone-resistant cancer: present-day drug prophylaxis and treatment].

  Sivkov AV, Alfimov AE, Imamov OE. Sivkov AV, et al. Urologiia. 1999 Sep-Oct;(5):33-9. Urologiia. 1999. PMID: 11150155 Review. Russian. No abstract available.
• [Therapy of carcinoma of the prostate].

  Zingg EJ. Zingg EJ. Schweiz Rundsch Med Prax. 1971 Mar 23;60(12):379-83. Schweiz Rundsch Med Prax. 1971. PMID: 4103477 German. No abstract available.
• [Endocrine treatment of metastatic cancer of breast and prostate].

  LUFT R, OLIVECRONA H, IKKOS D. LUFT R, et al. Nord Med. 1957 Jan 24;57(4):127-30. Nord Med. 1957. PMID: 13419106 Norwegian. No abstract available.
• The role of hormonal therapy in the treatment of prostatic carcinoma.

  Di Silverio F, D'eramo G, Caponera M, Flammia GP, Izzi R, Sciarra A, Macrì D, Buscarini M. Di Silverio F, et al. Rays. 1993 Jan-Mar;18(1):94-114. Rays. 1993. PMID: 8356245 Review. English, Italian. No abstract available.